Developers: | Quanovate |
Last Release Date: | September 2018 |
Branches: | Pharmaceuticals, medicine, healthcare |
Content |
2021: Start selling home tests for progesterone
In early December 2021, new Mira home tests went on sale. This progesterone test helps women maximize their chances of conception and monitor their reproductive health. The device connects to the smartphone and the user can get acquainted with the results in the smartphone application, which displays trends and data on hormone levels.
Fertility problems are rising, sperm counts are falling, and many couples have difficulty conceiving. This technology can help maximize the potential of conception by allowing women to track their cycle and observe trends in hormone levels that can reveal problems or highlight opportunities for conception. The device is a urinary wand that determines the glucuronide of pregnanediol, which provides confirmation of ovulation.
To start using the technology, you must download the application and connect it to the analyzer via bluetooth. Tests can be taken at any time during the day, provided that each day the user will take tests at about the same time. The company recommends using the device in the morning. The user needs to put the test stick down in the urine for 10 seconds, insert the stick into the Mira analyzer and wait about 15 minutes until the results appear in the application. The application uses artificial intelligence (AI) algorithms to study the user's hormonal background for highly personalized and accurate ovulation prediction. Users can see their digital hormone levels in the app, as well as hormone curves, ratios and patterns.
This information allows women to better understand their reproductive health and determine when users are most likely to conceive. Mira also offers two other hormonal sticks - Mira Fertility, which defines the luteinizing hormone and Mira Fertility Plus, defines the luteinizing hormone with estrogen. As of December 2021, the device is testing the concentration of luteinizing hormone, which is an indicator of ovulation, an estrogen metabolite that is a key component for understanding reproductive health and a progesterone metabolite in the urine that confirms ovulation. Unlike other digital ovulation tracking tools, the device measures the exact concentration of hormones in the urine and provides digital readings that are easy for users to understand.[1]
2018: Start of Sales
On September 7, 2018, the sale of Mira artificial intelligence-based gadget began, which tells a woman ideal days for conceiving a child by measuring the concentration of luteinizing hormone in urine samples. Unlike conventional tests, Mira provides accurate quantitative data, analyzes them, and provides an individualized forecast based on them.
This gadget was developed by Quanovate, which was founded at the end of 2015 by a group of scientists, engineers, gynaecologists and business managers. They note that the concentration of female hormones changes daily, with the profile of changes depending on lifestyle, stress levels and other factors. To determine the ideal days for conception, a woman needs to constantly monitor the level of homons, and this can only be done at home, and in this case Mira becomes a good helper.
The system consists of a small portable analyzer, strips for urine analysis and a special mobile application. The device determines the concentration of luteinizing hormone, which is an indicator of ovulation, and transmits information to the application, and an individual report is displayed on the screen.
The company plans to launch a whole line of tests for various hormones, suggesting that the device can also be used to determine pregnancy and menopause. In addition, Quanovate is working on a portal for physicians who will be able to access their patients' data for further analysis and in-depth consultation. Anonymous data can also be used for research, but so far the company has not taken steps in this direction.
The Mira device with ten test strips costs $199 and is available for ordering on the company's website.[2]